Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

ISSN： 1543-7671

Source： Journal of Cancer Pain & Symptom Palliation, Vol.2, Iss.3, 2008-01, pp. : 5-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Is the Use of Selective COX Inhibitors Associated with an Increased Risk of Cardiovascular Events?

Heart Drug, Vol. 4, Iss. 2, 2004-05 ,pp. : 92-95

Karger

Access to resources Recommend Favorite

Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?

By Chiolero Arnaud Burnier Michel Maillard Marc P

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 45-52

Informa Healthcare

Access to resources Recommend Favorite

COX-2 selective inhibitors: analysis of the renal effects

By Perazella Mark A

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 53-64

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal Safety of Selective COX-2 Inhibitors

Current Pharmaceutical Design, Vol. 8, Iss. 12, 2002-06 ,pp. : 1077-1089

Bentham Science Publishers

Access to resources Recommend Favorite